Tumor News and Research

RSS

Scientists uncover mechanism that prevents tumor growth in melanoma

Natural Killer (NK) cells, lymphocytes of the innate immune system with strong cytotoxic activity, play a major role in the immune response against tumors.

8 Nov 2017

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Researchers investigating ways to deliver high doses of cancer-killing drugs inside tumors have shown they can use a laser and light-activated gold nanoparticles to remotely trigger the release of approved cancer drugs inside cancer cells in laboratory cultures.

8 Nov 2017

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death.

8 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

In its latest pioneering effort to harness the power of focused ultrasound to battle disease, the University of Virginia Health System is examining the scalpel-free surgery's potential to enable the body to identify and destroy metastatic breast cancer cells.

8 Nov 2017

New program targets cancers affecting the liver and bile ducts

Cancers affecting the liver and bile ducts will be the target of a new program at Perlmutter Cancer Center at NYU Langone Health to provide multidisciplinary clinical care and rapidly bring important new research to the clinic.

7 Nov 2017

Researchers find new way to restrict ability of cancer to use glucose for energy

Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has long been considered a logical therapeutic strategy.

7 Nov 2017

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Researchers discover how traffic jam in intracellular sorting can cause tumor development

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer.

6 Nov 2017

Biologics do not raise risk of second cancer diagnosis in RA patients

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

6 Nov 2017

Pioneering research to grow mini bowel cancer tumor models in the lab

Charity Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research program aimed at finding new treatments for bowel cancer.

6 Nov 2017

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

Pre-menopausal women with the most common type of advanced breast cancer are usually excluded from medical research unnecessarily, according to an expert panel at the Advanced Breast Cancer Fourth International Consensus Conference.

6 Nov 2017

Four main genes linked to survival of pancreatic cancer patients

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

3 Nov 2017

Gut bacteria can influence how cancer responds to immunotherapy

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

2 Nov 2017

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.

2 Nov 2017

Preclinical studies show effectiveness of targeted therapy for glioblastoma

The targeted therapy onalespib has shown effectiveness in preclinical studies of glioblastoma by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

2 Nov 2017

Tumor News and Research

Scientists uncover mechanism that prevents tumor growth in melanoma

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Novel approach could help predict how well patients respond to cancer treatment

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

New program targets cancers affecting the liver and bile ducts

Researchers find new way to restrict ability of cancer to use glucose for energy

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

FDA approves first targeted cancer treatment based on basket study

FDA grants approval to first treatment for rare blood cancer

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

FDA approves new drug Zelboraf for Erdheim-Chester disease

Researchers discover how traffic jam in intracellular sorting can cause tumor development

Biologics do not raise risk of second cancer diagnosis in RA patients

Pioneering research to grow mini bowel cancer tumor models in the lab

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

Four main genes linked to survival of pancreatic cancer patients

Gut bacteria can influence how cancer responds to immunotherapy

Researchers develop new, three-step system to eliminate colorectal cancer

Preclinical studies show effectiveness of targeted therapy for glioblastoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News